AbbVie's head of global head of immunology discovery research says the ability to profile patients at the molecular level has the potential to dramatically change treatment for people living with chronic conditions. …
New testing means patients no longer 'defined by their symptoms'
February 26, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Draft 'National Health Genomics Policy Framework' out for consultation
July 3, 2025 - - Latest News -
MedAdvisor announces agreement confirming the sale of Australian business
July 3, 2025 - - Latest News -
GBMA announces planned departure of long-standing CEO
July 2, 2025 - - Latest News -
Neurizon announces global agreement with Elanco for the commercialisation of NUZ-001
July 2, 2025 - - Australian Biotech -
Prescient Therapeutics opens share purchase plan
July 2, 2025 - - Australian Biotech -
Amplia Therapeutics announces additional confirmed partial response recorded in ACCENT trial
July 2, 2025 - - Australian Biotech -
Island Pharmaceuticals announces the appointment of new chair
July 2, 2025 - - Australian Biotech